Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 75-81

  Pilcer, Gabrielle ^a   Vanderbist, Francis ^b   Amighi, Karim ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Laboratoires SMB SA   (Belgium)

Author keywords

Dry powder aerosols; Inertial impaction; Laser diffraction; Particle size distribution; Spraytec

Indexed keywords

AEROSOL; ANALYZER; ARTICLE; CORRELATION ANALYSIS; DISPERSION; DRUG FORMULATION; FLOW RATE; LASER DIFFRACTION; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; QUALITY CONTROL; SPRAY DRYING;

AEROSOLS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; LASERS; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; TOBRAMYCIN;

EID: 44449099553     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.02.014     Document Type: Article

References (27)

1. Annapragada A., and Adjei A. An analysis of the fraunhofer diffraction method for particle size distribution analysis and its application to aerolised sprays. Int. J. Pharm. 127 (1996) 219-227
2. Bland J., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
3. Bosquillon C., Lombry C., Preat V., and Vanbever R. Comparison of particle sizing techniques in the case of inhalation dry powders. J. Pharm. Sci. 90 (2001) 2032-2041
4. Bosquillon C., Rouxhet P., Ahimou F., Simon D., Culot C., Préat V., and Vanbever R. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J. Control Release 99 (2004) 357-367
5. Bridges P.A., and Taylor K.M.G. Nebulizers for the generation of liposomal aerosols. Int. J. Pharm. 173 (1998) 117-125
6. Clark A.R. The use of laser diffraction for the evaluation of aerosol clouds generated by medical nebulisers. Int. J. Pharm. 115 (1995) 69-78
7. Crowder T.M., Rosati J.A., Schroeter J.D., Hickey A.J., and Martonen T.B. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development. Pharm. Res. 19 (2002) 239-245
8. De Boer A.H., Gjaltema D., Hagedoorn P., and Frijnlink H.W. Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. Int. J. Pharm. 249 (2002) 219-231
9. Elversson J., Millqvist-Fureby A., Alderborn G., and Elofsson U. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray-drying. J. Pharm. Sci. 92 (2003) 900-910
10. ® with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J. Pharm. Sci. 93 (2004) 349-363
11. Heyder J., Gebhart J., Rudolf G., Schiller C.F., and Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J. Aerosol. Sci. 17 (1986) 811-825
12. Hickey A.J. An investigation of size deposition upon individual stages of a cascade impactor. Drug Dev. Ind. Pharm. 16 (1990) 1911-1929
13. Kamiya A., Sakagami M., Hindle H., and Byron P.B. Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and next generation pharmaceutical impactors and their USP methods. J. Pharm. Sci. 93 (2004) 1828-1837
14. Linnet K. Estimation of the linear relationship between the measurements of two methods with proportional errors. Stat. Med. 9 (1990) 1463-1473
15. Linnet K. Performance of Deming regression analysis in case of misspectified analytical error ratio in method comparison studies. Clin. Chem. 44 (1998) 1024-1031
16. Marriott C., MacRitchie H.B., Zeng X.M., and Martin G.P. Development of a laser diffraction method for the determination of the particle size of aerolised powder formulations. Int. J. Pharm. 326 (2006) 39-49
17. Martin G.P., MacRtchie H.B., Marriott C., and Zeng X.M. Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction laser diffraction. Pharm. Res. 23 (2006) 2210-2219
18. Mc Callion O.N.M., Taylor K.M.G., Thomas M., and Taylor A.J. The influence of surface tension on aerosols produced by medical nebulisers. Int. J. Pharm. 129 (1996) 123-136
19. Moren F. Pressurized aerosols for inhalation. Int. J. Pharm. 8 (1981) 1-10
20. Olsson B., Jaegfeldt H., Hed K., and Ludback H. Correlation between laser scattering and inertial impaction for the particle distribution characterisation of Bricanyl Turbohaler. J. Aerosol. Sci. 19 (1988) 1107-1111
21. Olsson B., Aiache J.M., Bull H., Ganderton D., Haywood P., Meakin B.J., Schorn P.J., and Wright P. The use of inertial impactors to measure the fine particle dose generated by inhalers. Pharmeuropa 8 (1996) 291-298
22. Pilcer G., Sebti Th., and Amighi K. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation. Pharm. Res. 23 (2006) 931-940
23. Stockl D., Dewitte K., and Thienpont L.M. Validity of linear regression in method comparison studies: is it limited by the statistical model or the quality of the analytical input data. Clin. Chem. 44 (1998) 2340-2346
24. Telko M.J., and Hickey A.J. Dry powder inhaler formulation. Respir. Care 50 (2005) 1209-1227
25. Vanbever R., Mintzes J.D., Wang J., Nice J., Chen D., Batycky R., Langer R., and Edwards D.A. Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16 (1999) 1753-1742
26. Westgard J.O. Points of care in using statistics in method comparison studies. Clin. Chem. 44 (1998) 2240-2242
27. Zeng X.M., MacRtchie H.B., Marriott C., and Martin G.P. Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations. Pharm. Res. 23 (2006) 2200-2209